Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2011)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; DUARTE, GERALDO - FMRP
- Unidade: FMRP
- DOI: 10.1038/tpj.2011.31
- Subjects: POLIMORFISMO; HIPERTENSÃO NA GRAVIDEZ (TERAPIA); PRÉ-ECLÂMPSIA; FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 3, n. 3, on-line, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PALEI, A. C. T. et al. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 3, n. 3, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.31. Acesso em: 29 dez. 2025. -
APA
Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Cavalli, R. de C., Lacchini, R., et al. (2011). Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 3( 3). doi:10.1038/tpj.2011.31 -
NLM
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Tanus-Santos JE. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1038/tpj.2011.31 -
Vancouver
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Tanus-Santos JE. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1038/tpj.2011.31 - Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy
- Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy
- Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
- Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
- Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia
- Maternal flow-mediated dilation and nitrite concentration during third trimester of pregnancy and postpartum period
- Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy
- Predição de pré-eclâmpsia [Editorial]
Informações sobre o DOI: 10.1038/tpj.2011.31 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
